Capital Asset Advisory Services LLC X4 Pharmaceuticals, Inc Transaction History
Capital Asset Advisory Services LLC
- $2.01 Billion
- Q4 2024
Shares
2 transactions
Others Institutions Holding XFOR
# of Institutions
98Shares Held
99.6MCall Options Held
421KPut Options Held
80.6K-
Bain Capital Life Sciences Investors, LLC Boston, MA16.9MShares$5.24 Million3.52% of portfolio
-
Nea Management Company, LLC Timonium, MD15MShares$4.65 Million0.82% of portfolio
-
Black Rock Inc. New York, NY10.7MShares$3.31 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.2MShares$2.54 Million0.0% of portfolio
-
Acorn Capital Advisors, LLC New York, NY7.31MShares$2.27 Million2.9% of portfolio
About X4 Pharmaceuticals, Inc
- Ticker XFOR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,646,096
- Market Cap $21.3M
- Description
- X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...